Literature DB >> 20145530

Quantification of circulating regulatory T cells by flow cytometry in kidney transplant patients after basiliximab induction therapy.

Farida Abadja, Eric Alamartine, François Berthoux, Christophe Mariat, Christian Genin, Claude Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20145530     DOI： 10.1097/TP.0b013e3181bbbd67

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.

Authors:  Gunnar Brandhorst; Darinka Todorova Petrova; Sebastian Weigand; Christoph Eberle; Nicolas von Ahsen; Jessica Schmitz; Frank Christian Schultze; Dirk Raddatz; Michael Karaus; Michael Oellerich; Philip D Walson
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

2.  The protein kinase C inhibitor sotrastaurin allows regulatory T cell function.

Authors:  A de Weerd; M Kho; R Kraaijeveld; J Zuiderwijk; W Weimar; C Baan
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

3.  Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.

Authors:  Jacobo López-Abente; Marta Martínez-Bonet; Esther Bernaldo-de-Quirós; Manuela Camino; Nuria Gil; Esther Panadero; Juan Miguel Gil-Jaurena; Maribel Clemente; Simon Urschel; Lori West; Marjorie Pion; Rafael Correa-Rocha
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance.

Authors:  Eva Krepsova; Irena Tycova; Alena Sekerkova; Peter Wohlfahrt; Petra Hruba; Ilja Striz; Birgit Sawitzki; Ondrej Viklicky
Journal:  BMC Nephrol       Date:  2015-08-19       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.